These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1651755)

  • 1. Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide.
    Solera J; Magallón M; Martin-Villar J; Coloma A
    Br J Haematol; 1991 Jul; 78(3):385-9. PubMed ID: 1651755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide.
    Huang MN; Kasper CK; Roberts HR; Stafford DW; High KA
    Blood; 1989 Feb; 73(3):718-21. PubMed ID: 2563663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factor IXLincoln Park: a molecular characterization.
    Rao KJ; Lyman G; Hamsbhushanam K; Scott JP; Jagadeeswaran P
    Mol Cell Probes; 1990 Oct; 4(5):335-40. PubMed ID: 1980717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutations in four hemophilia B patients from China.
    Wang NS; Chen SH; Thompson AR
    Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity.
    Green PM; Montandon AJ; Ljung R; Bentley DR; Nilsson IM; Kling S; Giannelli F
    Br J Haematol; 1991 Jul; 78(3):390-7. PubMed ID: 1873221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor IX gene mutations causing haemophilia B: comparison of SSC screening versus systematic DNA sequencing and diagnostic applications.
    Aguilar-Martinez P; Romey MC; Schved JF; Gris JC; Demaille J; Claustres M
    Hum Genet; 1994 Sep; 94(3):287-90. PubMed ID: 8076946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion.
    Ljung R; Green P; Sjörin E; Giannelli F; Nilsson IM
    Eur J Haematol; 1992 Oct; 49(4):215-8. PubMed ID: 1464363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm.
    Taylor SA; Liddell MB; Peake IR; Bloom AL; Lillicrap DP
    Br J Haematol; 1990 Jun; 75(2):217-21. PubMed ID: 2372509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
    Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
    J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct carrier testing of haemophilia B by SSCP.
    Martinez PA; Romey MC; Schved JF; Gris JC; Demaille J; Claustres M
    Clin Lab Haematol; 1994 Mar; 16(1):15-20. PubMed ID: 7913672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.
    Davis LM; McGraw RA; Ware JL; Roberts HR; Stafford DW
    Blood; 1987 Jan; 69(1):140-3. PubMed ID: 3790720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS; Zhang M; Thompson AR; Chen SH
    Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
    Driscoll MC; Bouhassira E; Aledort LM
    Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a factor IX point mutation using SSCP analysis and direct sequencing.
    Demers DB; Odelberg SJ; Fisher LM
    Nucleic Acids Res; 1990 Sep; 18(18):5575. PubMed ID: 2216751
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
    Tartary M; Vidaud D; Piao Y; Costa JM; Bahnak BR; Fressinaud E; Congard B; Laurian Y; Meyer D; Lavergne JM
    Br J Haematol; 1993 Aug; 84(4):662-9. PubMed ID: 8217825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
    Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
    Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.